Bank Of Montreal Amyris, Inc. Transaction History

Bank Of Montreal

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$0.58 - $1.3 $57,222 - $128,258	-98,660 Reduced 10.1%	878,358 $904,000
Q1 2023 Jun 13, 2024	BUY	$1.09 - $1.82 $986,748 - $1.65 Million	905,274 New	905,274 $1.23 Million
Q4 2022 Feb 01, 2023	SELL	$1.52 - $3.39 $190,120 - $424,017	-125,079 Reduced 11.35%	977,018 $1.49 Million
Q3 2022 Nov 10, 2022	SELL	$1.7 - $4.05 $39,803 - $94,826	-23,414 Reduced 2.08%	1,102,097 $3.6 Million
Q2 2022 Aug 11, 2022	SELL	$1.6 - $5.07 $559,616 - $1.77 Million	-349,760 Reduced 23.71%	1,125,511 $2.48 Million
Q1 2022 May 12, 2022	SELL	$3.92 - $5.86 $289,515 - $432,796	-73,856 Reduced 4.77%	1,475,271 $6.82 Million
Q4 2021 Feb 11, 2022	BUY	$5.0 - $14.85 $7.75 Million - $23 Million	1,549,127 New	1,549,127 $8.44 Million

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.